Ramy Sedhom Shares Study on Inpatient Immunotherapy Outcomes
Ramy Sedhom, Clinical Director of Palliative Care at Penn Medicine Princeton Health, shared a post on X about a recent article by Fauzia Riaz et al., published in JCO Oncology Practice.
“Great editorial Ali Khaki, Laura Petrillo in JCO Oncology Practice.
Reporting on use of inpatient ICI ~ median OS 2 mo.
Sad we greenlight 6-figure immunotherapy – but tell dying pts on hospice there’s ‘no funding'[ for better support at home.”
Title: Inpatient Immunotherapy Outcomes Study: A Multicenter Retrospective Analysis
Authors: Fauzia Riaz, John L. Vaughn, Huili Zhu, James C. Dickerson, Hoda E. Sayegh, Samantha Brongiel, Elena Baldwin, Melanie W. Kier, Jacob Zaemes, Caleb Hearn, Osama Abdelghany, Roger B. Cohen, Ravi B. Parikh, Joshua E. Reuss, Elizabeth Prsic, Deborah B. Doroshow
Read The Full Article at JCO Oncology Practice.
More posts featuring Ramy Sedhom.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023